Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

BPC-157 + TB-500 20 mg blend

Buy BPC-157 + TB-500 blend 20 mg for laboratory research. Each boxed 3 mL vial contains 10 mg of BPC-157 and 10 mg of TB-500 as lyophilized powder, for 20 mg total labeled material.

  • BPC-157: 10 mg per vial
  • TB-500: 10 mg per vial
  • Total blend: 20 mg per vial

The TB-500 supplied in this product is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.

Choose the size and composition

The 10 mg blend has the same labeled 1:1 mass ratio in a different total amount. Equal milligram amounts do not imply equal numbers of molecules; molar comparisons require the molecular identity of each supplied component.

A premixed vial fixes those proportions. Separate BPC-157 and TB-500 products allow the compounds to be selected independently. This two-component blend does not contain KPV or GHK-Cu.

What the component research establishes

Chang and colleagues studied BPC-157 in rat Achilles tendon explants and cultured tendon fibroblasts. They observed increased outgrowth and migration, while the proliferation assay showed no direct increase. The measurements concern BPC-157 under those experimental conditions, rather than the performance of this combined product.

The TB-500 component uses the full-length thymosin beta-4 identity stated above. Esposito and colleagues analyzed an acetylated seven-residue fragment in a different preparation sold as TB-500. Their study concerns that fragment, not this product’s full-length component or the combined blend.

Review the blend’s COA and product files

COA & Documents contains the available batch reports and product documentation. Check the lot and size, the identity assigned to each component, and whether the report measures each peptide’s content separately. A combined purity percentage does not by itself confirm both labeled amounts.

The composition above describes labeled material, not a measured result for every lot. For handling and storage, consult records applicable to the complete mixture. The 3 mL specification is vial capacity, not an included liquid volume or a preparation instruction.

Additional information

CAS No.

BPC-157: 137525-51-0, TB-500: 77591-33-4

Purity

≥99%

Applications

Tissue repair research, inflammation studies, muscle and tendon regeneration investigations.

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for 24 months at -20°C in lyophilized form.

Appearance

White crystalline powder

Shipping Conditions

Shipped at room temperature. Upon receipt, store at -20°C

Regulatory/Compliance

Complies with research use only standards. Not for drug, household, or other uses.

Safety Information

Refer to MSDS; handle according to established laboratory safety procedures

COA & Documents

Independent lot testing

BPC-157 + TB-500 (20mg Blend) Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
48182
Report number
IF-824-QSA-TR006-BTL2649-09
Date tested
March 18, 2026
Reported purity
99.8%
Labeled content
20 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for BPC-157 + TB-500 (20mg Blend).

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support